Spinal Muscular Atrophy Medicine and Forecast Market

List of Tables
Table 1. Key Players of Spinal Muscular Atrophy Medicine in Global Market
Table 2. Top Spinal Muscular Atrophy Medicine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Spinal Muscular Atrophy Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Spinal Muscular Atrophy Medicine Revenue Share by Companies, 2017-2022
Table 5. Global Spinal Muscular Atrophy Medicine Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Spinal Muscular Atrophy Medicine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Spinal Muscular Atrophy Medicine Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Spinal Muscular Atrophy Medicine Product Type
Table 9. List of Global Tier 1 Spinal Muscular Atrophy Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Spinal Muscular Atrophy Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Spinal Muscular Atrophy Medicine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Spinal Muscular Atrophy Medicine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Spinal Muscular Atrophy Medicine Sales (K Pcs), 2017-2022
Table 15. By Type - Global Spinal Muscular Atrophy Medicine Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Spinal Muscular Atrophy Medicine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Spinal Muscular Atrophy Medicine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Spinal Muscular Atrophy Medicine Sales (K Pcs), 2017-2022
Table 20. By Application - Global Spinal Muscular Atrophy Medicine Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Spinal Muscular Atrophy Medicine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Spinal Muscular Atrophy Medicine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Spinal Muscular Atrophy Medicine Sales (K Pcs), 2017-2022
Table 25. By Region - Global Spinal Muscular Atrophy Medicine Sales (K Pcs), 2023-2028
Table 26. By Country - North America Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Sales, (K Pcs), 2023-2028
Table 46. Astellas Pharma Inc. Corporate Summary
Table 47. Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Product Offerings
Table 48. Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. AveXis, Inc. Corporate Summary
Table 50. AveXis, Inc. Spinal Muscular Atrophy Medicine Product Offerings
Table 51. AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Bioblast Pharma Ltd. Corporate Summary
Table 53. Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Product Offerings
Table 54. Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Cytokinetics, Inc. 24 Corporate Summary
Table 56. Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Product Offerings
Table 57. Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 59. F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Product Offerings
Table 60. F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Genethon Corporate Summary
Table 62. Genethon Spinal Muscular Atrophy Medicine Product Offerings
Table 63. Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Genzyme Corporation Corporate Summary
Table 65. Genzyme Corporation Spinal Muscular Atrophy Medicine Product Offerings
Table 66. Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. GMP-Orphan SAS Corporate Summary
Table 68. GMP-Orphan SAS Spinal Muscular Atrophy Medicine Product Offerings
Table 69. GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Ionis Pharmaceuticals, Inc. Corporate Summary
Table 71. Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Product Offerings
Table 72. Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Longevity Biotech, Inc Corporate Summary
Table 74. Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Product Offerings
Table 75. Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Neurodyn Inc. Corporate Summary
Table 77. Neurodyn Inc. Spinal Muscular Atrophy Medicine Product Offerings
Table 78. Neurodyn Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Neurotune AG Corporate Summary
Table 80. Neurotune AG Spinal Muscular Atrophy Medicine Product Offerings
Table 81. Neurotune AG Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Novartis AG Corporate Summary
Table 83. Novartis AG Spinal Muscular Atrophy Medicine Product Offerings
Table 84. Novartis AG Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Sarepta Therapeutics, Inc. Corporate Summary
Table 86. Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Product Offerings
Table 87. Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Voyager Therapeutics, Inc. Corporate Summary
Table 89. Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Product Offerings
Table 90. Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Vybion, Inc. Corporate Summary
Table 92. Vybion, Inc. Spinal Muscular Atrophy Medicine Product Offerings
Table 93. Vybion, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. WAVE Life Sciences Ltd. Corporate Summary
Table 95. WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Product Offerings
Table 96. WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Spinal Muscular Atrophy Medicine Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 98. Global Spinal Muscular Atrophy Medicine Capacity Market Share of Key Manufacturers, 2020-2022
Table 99. Global Spinal Muscular Atrophy Medicine Production by Region, 2017-2022 (K Pcs)
Table 100. Global Spinal Muscular Atrophy Medicine Production by Region, 2023-2028 (K Pcs)
Table 101. Spinal Muscular Atrophy Medicine Market Opportunities & Trends in Global Market
Table 102. Spinal Muscular Atrophy Medicine Market Drivers in Global Market
Table 103. Spinal Muscular Atrophy Medicine Market Restraints in Global Market
Table 104. Spinal Muscular Atrophy Medicine Raw Materials
Table 105. Spinal Muscular Atrophy Medicine Raw Materials Suppliers in Global Market
Table 106. Typical Spinal Muscular Atrophy Medicine Downstream
Table 107. Spinal Muscular Atrophy Medicine Downstream Clients in Global Market
Table 108. Spinal Muscular Atrophy Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Spinal Muscular Atrophy Medicine Segment by Type
Figure 2. Spinal Muscular Atrophy Medicine Segment by Application
Figure 3. Global Spinal Muscular Atrophy Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Spinal Muscular Atrophy Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Spinal Muscular Atrophy Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. Spinal Muscular Atrophy Medicine Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Spinal Muscular Atrophy Medicine Revenue in 2021
Figure 9. By Type - Global Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
Figure 10. By Type - Global Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Spinal Muscular Atrophy Medicine Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
Figure 13. By Application - Global Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Spinal Muscular Atrophy Medicine Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
Figure 16. By Region - Global Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
Figure 19. US Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
Figure 24. Germany Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. France Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
Figure 33. China Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. India Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
Figure 40. Brazil Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Spinal Muscular Atrophy Medicine Sales Market Share, 2017-2028
Figure 44. Turkey Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Spinal Muscular Atrophy Medicine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Spinal Muscular Atrophy Medicine Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Spinal Muscular Atrophy Medicine by Region, 2021 VS 2028
Figure 50. Spinal Muscular Atrophy Medicine Industry Value Chain
Figure 51. Marketing Channels